These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38656653)

  • 1. Systematic Literature Review on the Incidence of Herpes Zoster in Populations at Increased Risk of Disease in the EU/EEA, Switzerland, and the UK.
    Marijam A; Vroom N; Bhavsar A; Posiuniene I; Lecrenier N; Vroling H
    Infect Dis Ther; 2024 May; 13(5):1083-1104. PubMed ID: 38656653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes Zoster Risk in Immunocompromised Adults in the United States: A Systematic Review.
    McKay SL; Guo A; Pergam SA; Dooling K
    Clin Infect Dis; 2020 Oct; 71(7):e125-e134. PubMed ID: 31677266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccines for preventing herpes zoster in older adults.
    de Oliveira Gomes J; Gagliardi AM; Andriolo BN; Torloni MR; Andriolo RB; Puga MEDS; Canteiro Cruz E
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD008858. PubMed ID: 37781954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for herpes zoster: should people with asthma or COPD be vaccinated?
    Safonova E; Yawn BP; Welte T; Wang C
    Respir Res; 2023 Jan; 24(1):35. PubMed ID: 36709298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes Zoster Recurrence: A Narrative Review of the Literature.
    Parikh R; Spence O; Giannelos N; Kaan I
    Dermatol Ther (Heidelb); 2024 Mar; 14(3):569-592. PubMed ID: 38416279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines for preventing herpes zoster in older adults.
    Gagliardi AM; Andriolo BN; Torloni MR; Soares BG; de Oliveira Gomes J; Andriolo RB; Canteiro Cruz E
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31696946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of the evidence on the epidemiology of herpes zoster: incidence in the general population and specific subpopulations in Spain.
    Mareque M; Oyagüez I; Morano R; Casado MA
    Public Health; 2019 Feb; 167():136-146. PubMed ID: 30660981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of Herpes Zoster in Adult Patients with Underlying Conditions: Analysis of German Claims Data, 2007-2018.
    Batram M; Witte J; Schwarz M; Hain J; Ultsch B; Steinmann M; Bhavsar A; Wutzler P; Criée CP; Hermann C; Wahle K; Füchtenbusch M; Greiner W
    Dermatol Ther (Heidelb); 2021 Jun; 11(3):1009-1026. PubMed ID: 33959878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions.
    Sullivan KM; Farraye FA; Winthrop KL; Willer DO; Vink P; Tavares-Da-Silva F
    Vaccine; 2023 Jan; 41(1):36-48. PubMed ID: 36460534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic literature review to assess the burden of herpes zoster disease in China.
    Yin D; Van Oorschot D; Jiang N; Marijam A; Saha D; Wu Z; Tang H; Diaz-Decaro J; Watson P; Xie X; Ren Y; He Y; Feng Y
    Expert Rev Anti Infect Ther; 2021 Feb; 19(2):165-179. PubMed ID: 32997550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of herpes zoster in 16 selected immunocompromised populations in England: a cohort study in the Clinical Practice Research Datalink 2000-2012.
    Yanni EA; Ferreira G; Guennec M; El Hahi Y; El Ghachi A; Haguinet F; Espie E; Bianco V
    BMJ Open; 2018 Jun; 8(6):e020528. PubMed ID: 29880565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of herpes zoster in the Japanese population with immunocompromising and chronic disease conditions: Results from a claims database cohort study, from 2005 to 2014.
    Imafuku S; Dormal G; Goto Y; Jégou C; Rosillon D; Matsuki T
    J Dermatol; 2020 Mar; 47(3):236-244. PubMed ID: 31953880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant zoster vaccine in immunocompetent and immunocompromised adults: A review of clinical studies.
    Mwakingwe-Omari A; Lecrenier N; Naficy A; Curran D; Posiuniene I
    Hum Vaccin Immunother; 2023 Dec; 19(3):2278362. PubMed ID: 37965770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study.
    Zhang J; Delzell E; Xie F; Baddley JW; Spettell C; McMahan RM; Fernandes J; Chen L; Winthrop K; Curtis JR
    Arthritis Res Ther; 2011; 13(5):R174. PubMed ID: 22024532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer.
    Curran D; Patterson BJ; Carrico J; Salem A; La EM; Lorenc S; Hicks KA; Poston S; Carpenter CF
    Hum Vaccin Immunother; 2023 Dec; 19(1):2167907. PubMed ID: 36880669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
    Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
    J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar herpes zoster incidence across Europe: results from a systematic literature review.
    Pinchinat S; Cebrián-Cuenca AM; Bricout H; Johnson RW
    BMC Infect Dis; 2013 Apr; 13():170. PubMed ID: 23574765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of Herpes Zoster Among Patients with Psoriasis in the United States.
    Singer D; Thompson-Leduc P; Ma S; Gupta D; Cheng WY; Sendhil SR; Sundar M; Hagopian E; Stempniewicz N; Duh MS; Poston S
    Dermatol Ther (Heidelb); 2023 Nov; 13(11):2649-2668. PubMed ID: 37740149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety Profile of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Populations: An Overview of Six Trials.
    López-Fauqued M; Co-van der Mee M; Bastidas A; Beukelaers P; Dagnew AF; Fernandez Garcia JJ; Schuind A; Tavares-da-Silva F
    Drug Saf; 2021 Jul; 44(7):811-823. PubMed ID: 34115324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.